scispace - formally typeset
J

Junjie Fang

Researcher at University of Pennsylvania

Publications -  10
Citations -  444

Junjie Fang is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Signal transduction & B cell. The author has an hindex of 6, co-authored 9 publications receiving 431 citations. Previous affiliations of Junjie Fang include Children's Hospital of Philadelphia & St. Jude Children's Research Hospital.

Papers
More filters
Journal ArticleDOI

Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.

TL;DR: It is found that rapamycin inhibited growth of B-precursor acute lymphoblastic leukemia lines in vitro, with evidence of apoptotic cell death, and that one of the growth signals inhibited by this class of drugs in precursor B leukemic cells may be IL-7-mediated.
Journal ArticleDOI

Thymic Stromal-Derived Lymphopoietin Induces Proliferation of Pre-B Leukemia and Antagonizes mTOR Inhibitors, Suggesting a Role for Interleukin-7Rα Signaling

TL;DR: It is shown that TSLP stimulates proliferation of pre-B ALL cell lines and partially reverses the effects of MTI on proliferation, apoptosis, and ribosomal protein S6 and 4E-BP1 phosphorylation in cell lines, with similar biological effects seen in some primary human lymphoblast samples.
Journal ArticleDOI

CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studies.

TL;DR: Data show that purging of NB from PBPC specimens using CD34 selection is feasible, yielding infused products that are negative at the level of ICC but often positive at thelevel of RT-PCR.
Journal Article

Cytoplasmic μ Heavy Chain Confers Sensitivity to Dexamethasone-induced Apoptosis in Early B-lineage Acute Lymphoblastic Leukemia

TL;DR: A role for the pre-BCR complex is suggested in the response of ALL cells to treatment and insight is provided into the mechanism of steroid response in the treatment of pre-B ALL.